111 related articles for article (PubMed ID: 23857671)
1. The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma.
Ren H; Zhao T; Sun J; Wang X; Liu J; Gao S; Yu M; Hao J
J Cell Biochem; 2013 Nov; 114(11):2603-11. PubMed ID: 23857671
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
Huang L; Ma B; Ma J; Wang F
Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
[TBL] [Abstract][Full Text] [Related]
4. High expression of CX3CL1/CX3CR1 axis predicts a poor prognosis of pancreatic ductal adenocarcinoma.
Xu X; Wang Y; Chen J; Ma H; Shao Z; Chen H; Jin G
J Gastrointest Surg; 2012 Aug; 16(8):1493-8. PubMed ID: 22639377
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
[TBL] [Abstract][Full Text] [Related]
6. The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.
Nevo I; Sagi-Assif O; Meshel T; Ben-Baruch A; Jöhrer K; Greil R; Trejo LE; Kharenko O; Feinmesser M; Yron I; Witz IP
Cancer Lett; 2009 Jan; 273(1):127-39. PubMed ID: 18778890
[TBL] [Abstract][Full Text] [Related]
7. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.
Marchesi F; Locatelli M; Solinas G; Erreni M; Allavena P; Mantovani A
J Neuroimmunol; 2010 Jul; 224(1-2):39-44. PubMed ID: 20630606
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophy of the ligament flavum in degenerative lumbar stenosis associated with the increased expression of fractalkine (CX3CL1)/CX3CR1 chemokine.
Oh IS; Suh DW; Ha KY
Connect Tissue Res; 2013; 54(6):380-5. PubMed ID: 24060055
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer.
Wei LM; Cao S; Yu WD; Liu YL; Wang JT
Oncol Rep; 2015 Feb; 33(2):615-24. PubMed ID: 25482732
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia increases CX3CR1 expression via HIF-1 and NF‑κB in androgen-independent prostate cancer cells.
Xiao LJ; Chen YY; Lin P; Zou HF; Lin F; Zhao LN; Li D; Guo L; Tang JB; Zheng XL; Yu XG
Int J Oncol; 2012 Nov; 41(5):1827-36. PubMed ID: 22941344
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.
Marchesi F; Piemonti L; Fedele G; Destro A; Roncalli M; Albarello L; Doglioni C; Anselmo A; Doni A; Bianchi P; Laghi L; Malesci A; Cervo L; Malosio M; Reni M; Zerbi A; Di Carlo V; Mantovani A; Allavena P
Cancer Res; 2008 Nov; 68(21):9060-9. PubMed ID: 18974152
[TBL] [Abstract][Full Text] [Related]
12. Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments.
Wada A; Ito A; Iitsuka H; Tsuneyama K; Miyazono T; Murakami J; Shibahara N; Sakurai H; Saiki I; Nakayama T; Yoshie O; Koizumi K; Sugiyama T
Oncol Rep; 2015 Jun; 33(6):2935-9. PubMed ID: 25962684
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus chemokine receptor US28 induces migration of cells on a CX3CL1-presenting surface.
Hjortø GM; Kiilerich-Pedersen K; Selmeczi D; Kledal TN; Larsen NB
J Gen Virol; 2013 May; 94(Pt 5):1111-1120. PubMed ID: 23303826
[TBL] [Abstract][Full Text] [Related]
14. Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Marchesi F; Basso G; Rahal D; Delconte G; Catalano M; Cappello P; Roncalli M; Zerbi A; Montorsi M; Novelli F; Mantovani A; Allavena P; Malesci A; Laghi L
Br J Cancer; 2013 Oct; 109(9):2424-33. PubMed ID: 24084767
[TBL] [Abstract][Full Text] [Related]
15. Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.
Schmall A; Al-Tamari HM; Herold S; Kampschulte M; Weigert A; Wietelmann A; Vipotnik N; Grimminger F; Seeger W; Pullamsetti SS; Savai R
Am J Respir Crit Care Med; 2015 Feb; 191(4):437-47. PubMed ID: 25536148
[TBL] [Abstract][Full Text] [Related]
16. Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition.
Morimura S; Sugaya M; Sato S
Am J Pathol; 2013 May; 182(5):1640-7. PubMed ID: 23470165
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.
Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR
Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
[TBL] [Abstract][Full Text] [Related]
19. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
20. Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue.
El-Shazly AE; Doloriert HC; Bisig B; Lefebvre PP; Delvenne P; Jacobs N
Clin Exp Allergy; 2013 Mar; 43(3):322-31. PubMed ID: 23414540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]